Skip to content

Stanford University School of Medicine

Nicholas Guardino

Biomedical scientist. Aspiring founder.
Bridging oncology research and entrepreneurship.

Nicholas Guardino, headshot

Scientist turned entrepreneur

PhD Candidate in Stem Cell Biology & Regenerative Medicine at Stanford, with 8+ years of combined experience in oncology, wound healing, and computational biology. I study how skin tumors evolve, metastasize, and resist treatment — with the long-term goal of translating discoveries into therapies and companies.

My research spans single-cell genomics, spatial transcriptomics, and in vivo functional studies across multiple institutions. I'm deeply involved in Stanford's entrepreneurship ecosystem through the Stanford Biotech Group and serve as President of the Student Body Government for the Stanford Stem Cell Program.

25+ Publications
8+ Years of Research
1 Patent Application
4 Institutions

A career built across top institutions

2024 — Present Stanford University

PhD Candidate, Dermatology & Oncology

Lab of Anthony Oro

Investigating tumor epithelial and microenvironmental states influencing tumor progression and drug resistance. Leveraging computational expertise to discover genomic and spatial transcriptomic alterations in metastatic disease.

2022 — 2023 Duke University

Research Analyst, Orthopedic Oncology

Lab of Benjamin Alman

Produced the first-ever single-cell RNA sequencing dataset of human chondrosarcoma. Discovered and functionally tested metastatic drivers of primary human chondrosarcoma in mouse lungs in vivo.

2020 — 2022 Stanford University

Life Science Research Professional, Surgery

Lab of Michael T. Longaker

Interrogated transdifferentiation between adipocytes and fibroblasts and their contribution to scarring. Discovered small molecule inhibitors of fibrosis, leading to a patent application now in large animal testing for Pre-IND.

2018 — 2020 USC

Research Assistant, Stem Cell Biology

Lab of Joseph T. Rodgers, Keck School of Medicine

Investigated priming injuries and their potential impact on nerve and muscle regeneration.

Summer 2015 Roche

Clinical Science Intern

Roche Headquarters, Basel, Switzerland

Assisted with Trial Master File (TMF) documentation, critical for FDA study approval.

Stanford University

PhD in Stem Cell Biology & Regenerative Medicine

Expected 2028/2029

University of Southern California

Bachelor of Science (B.S.)

May 2020

Published in leading journals

A selection from 25+ publications. View full list on Google Scholar →

Nature

Histological Signatures Map Anti-Fibrotic Factors in Mouse and Human Lungs

Guo J, ..., Guardino N.J, ..., Longaker M.T.

Cell Stem Cell

Allele-Specific Expression Reveals Genetic Drivers of Tissue Regeneration in Mice

Talbott HE*, Mack KL*, ..., Guardino NJ, ..., Longaker MT.

Cancer Cell

Multiomic Analysis Reveals Conservation of Cancer-Associated Fibroblast Phenotypes Across Species and Tissue of Origin

Foster D, ..., Guardino NJ, ..., Longaker MT.

Science Translational Medicine

Growth Arrest Specific-6 and Angiotoxin Receptor-Like Signaling Drive Oral Regenerative Wound Repair

Griffin M.*, Cook J.*, ..., Guardino N, ..., Longaker M.T.

Science Translational Medicine

Mechanotransduction Inhibition Prevents Scarring and Yields Regeneration in a Large Animal Model

Mascharak S, ..., Guardino N, ..., Longaker M.T.

Nature Biomedical Engineering

Targeting Circulating Mechanoresponsive Monocytes and Macrophages Reduces Fibrosis

Chen K.*, Griffin M.*, ..., Guardino N, ..., Gurtner G.C.

PNAS

Protein Phosphatase 1 Regulatory Subunit 3C Integrates Cholesterol and Isocitrate Dehydrogenase in Chondrocytes and Neoplasia

Nakagawa M, ..., Guardino N.J, ..., Alman B.A.

BMC Cancer

Targeting IKK-Mediated NF-kB Signaling in Metastatic Chondrosarcoma: A Novel Therapeutic Strategy

Mebrahtu A, ..., Guardino N, ..., Visgauss J.

iScience

The COMPASS Complex Maintains the Metastatic Capacity Imparted by a Subpopulation of Cells in UPS

Ban G. I, ..., Guardino N, ..., Alman B.A.

Cell Reports Medicine

Desmoplastic-Stromal Signatures Predict Patient Outcomes in Pancreatic Ductal Adenocarcinoma

Mascharak S*, Guo J*, ..., Guardino N, ..., Longaker M.

Piezo Inhibition for Wound Healing

Griffin M, Guardino N, Talbott HE, Januszyk M, Wan DC, Longaker M.T.

Currently in large animal testing for Pre-IND filing

President, Student Body Government

Stanford Stem Cell Biology & Regenerative Medicine Program

Running institute events, interviewing hires (staff & faculty), policy decisions, student recruitment

From bench to boardroom

I believe the next wave of transformative biotech companies will be founded by scientists who deeply understand the biology. My goal is to leverage my expertise in oncology, regenerative medicine, and multi-omic computational approaches to build therapies — and ultimately a company — that can change patient outcomes at scale.

I'm actively building at the intersection of science and entrepreneurship through Stanford's biotech and venture ecosystems, and I'm looking for collaborators, mentors, and investors who share this vision.

Deep Science

8+ years of hands-on research across oncology, wound healing, and computational biology

Translational Impact

Patent application in Pre-IND stage, targeting clinical relevance from day one

Founder Mindset

Active in Stanford Biotech Group and entrepreneurship programs, building toward company formation

Let's connect

Interested in discussing biotech ventures, collaborative research, or investment opportunities? I'd love to hear from you.